Mode
Text Size
Log in / Sign up

Meta-analysis links moderate-to-severe obstructive sleep apnea to higher metabolic syndrome risk in patientsPatients with worse sleep apnea face higher risks for diabetes and high blood pressure compared to those with milder cases

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider prioritizing metabolic syndrome screening for patients with moderate-to-severe obstructive sleep apnea syndrome.

This meta-analysis examined the association between obstructive sleep apnea syndrome (OSAS) severity and the risk of developing metabolic syndrome, hypertension, and hyperglycemia. The analysis pooled data from 10,205 participants to compare outcomes between those with moderate-to-severe OSAS and those with mild OSAS. The study setting was not reported, and no specific medications were analyzed.

Key findings indicated that the risk of developing metabolic syndrome was 2.18 times higher in the moderate-to-severe group (OR = 2.18, 95%CI: 1.30–3.68, P < 0.001). The risk of hypertension was also elevated at 2.19 times higher (OR = 2.19, 95%CI: 1.57–3.06, P < 0.05). Hyperglycemia risk was 1.50 times higher (OR = 1.50, 95%CI: 1.01–2.18).

The authors identified significant heterogeneity between studies published before 2016 (I2 = 54.6%, P = 0.051) and those published in or after 2016 (I2 = 65.2%, P = 0.035). Meta-regression analysis indicated that the heterogeneity in results regarding metabolic syndrome risk was primarily due to the year of publication. No adverse events or discontinuations were reported. The authors caution that these findings describe associations rather than causation.

This study looked at more than ten thousand people who had obstructive sleep apnea. The researchers compared those with mild breathing pauses during sleep to those with moderate or severe pauses. They found that the group with worse sleep apnea had much higher risks for health problems.

Specific health issues included metabolic syndrome, which is a cluster of conditions like high blood pressure and high blood sugar. People with moderate to severe sleep apnea were about two times more likely to develop metabolic syndrome than those with mild symptoms. The risk for high blood pressure was also about two times higher in the sicker group.

Even the risk for high blood sugar was significantly greater for patients with worse sleep apnea. This means that how bad the breathing pauses are matters a lot for future health. Doctors should check these patients carefully and start treatment early to help lower their risks.

The study noted that older studies showed more mixed results than newer ones. Still, the overall message is clear: worse sleep apnea leads to worse metabolic health. Screening and early action are very important for these patients.

What this means for you:
Worse sleep apnea greatly raises the risk for metabolic syndrome, high blood pressure, and high blood sugar compared to milder cases.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
This study aimed to systematically investigate the association between obstructive sleep apnea syndrome (OSAS) and metabolic syndrome (MetS), with a particular focus on severity–stratified analysis, in order to clarify the differential risks of MetS and its components (hypertension, hyperglycemia, etc. ) among patients with different levels of OSAS severity. A comprehensive literature search was conducted in Web of Science, PubMed, Cochrane, and Embase databases from their inception to June 1, 2025, using keywords related to “sleep apnea syndrome” and “MetS”. After rigorous quality evaluation and data extraction of the included studies, a stratified meta-analysis by OSAS severity was performed using Stata 17.0 software.Subgroup analysis and meta-regression were further applied to explore heterogeneity sources, enhancing the reliability of results. A total of 10 studies involving 10,205 participants were included. The meta-analysis revealed that the risk of developing MetS in patients with moderate-to-severe OSAS was 2.18 times higher than in those with mild OSAS (OR = 2.18, 95%CI:1.30–3.68, P < 0.001). The risk of hypertension in patients with moderate-to-severe OSAS was 2.19 times higher than that in patients with mild OSAS (OR = 2.19, 95%CI:1.57–3.06, P < 0.05). The risk of hyperglycemia in patients with moderate-to-severe OSAS was 1.50 times higher than that in patients with mild OSAS(OR = 1.50, 95%CI:1.01–2.18). Subgroup analysis results showed that heterogeneity existed between studies published before 2016 (I2 = 54.6%, P = 0.051) and those published in or after 2016 (I2 = 65.2%, P = 0.035). Meta-regression analysis indicated that the heterogeneity in the results of studies on the association between OSAS and the risk of MetS was primarily due to the year of publication of the literature (2016). This study found that patients with moderate to severe OSAS have a 2.18 times higher risk of developing MetS than those with mild OSAS. Their risk of hypertension and hyperglycemia also goes up significantly. For patients with moderate to severe OSAS, it makes sense to prioritize MetS screening and start early intervention to lower their risk of developing MetS.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.